Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Personalized Medicine|May 28, 2022
Three-Dimensional Evaluation of Isodose Radiation Volumes in Cases of Severe Mandibular Osteoradionecrosis for the Prediction of Recurrence after Segmental ResectionHaye H Glas, Joep Kraeima, Silke Tribius, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 22, 2016
Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94)Pirus Ghadjar, Christoph Pöttgen, Daniela Joos, et al.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Plos One|July 31, 2020
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patientsSebastian Zschaeck, Yimin Li, Qin Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 20, 2025
Oral health-related quality of life among long-term head and neck cancer survivors: a multinational studyKristine Løken Westgaard, Cecilie Delphin Amdal, Katherine J Taylor, et al.
Scientific Reports|October 20, 2020
A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiationYimin Li, Marcus Beck, Tom Päßler, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 22, 2025
Total lesion glycolysis of primary tumor and lymphnodes is a strong predictor for development of distant metastases in oropharyngeal carcinoma patients with independent validation in automatically delineated lesionsSebastian Zschaeck, Marina Hajiyianni, Patrick Hausmann, et al.
Frontiers in Oncology|September 3, 2024
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial)Marlen Haderlein, Jens von der Grün, Panagiotis Balermpas, et al.
Frontiers in Oncology|April 7, 2023
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trialSusanne Wiegand, Gunnar Wichmann, Jeannette Vogt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 6, 2025
Outcome Prediction in Older Adults With Head and Neck Cancer Undergoing ChemoradiationSebastian N Marschner, Elia Lombardo, Erik Haehl, et al.
Pageof 7